287 related articles for article (PubMed ID: 9550386)
21. Isolation of low molecular mass polypeptide complementary DNA clones from primitive vertebrates. Implications for the origin of MHC class I-restricted antigen presentation.
Kandil E; Namikawa C; Nonaka M; Greenberg AS; Flajnik MF; Ishibashi T; Kasahara M
J Immunol; 1996 Jun; 156(11):4245-53. PubMed ID: 8666794
[TBL] [Abstract][Full Text] [Related]
22. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome.
Driscoll J; Brown MG; Finley D; Monaco JJ
Nature; 1993 Sep; 365(6443):262-4. PubMed ID: 8371781
[TBL] [Abstract][Full Text] [Related]
23. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
Rechsteiner M; Realini C; Ustrell V
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes.
Aki M; Shimbara N; Takashina M; Akiyama K; Kagawa S; Tamura T; Tanahashi N; Yoshimura T; Tanaka K; Ichihara A
J Biochem; 1994 Feb; 115(2):257-69. PubMed ID: 8206875
[TBL] [Abstract][Full Text] [Related]
25. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.
Serwold T; Shastri N
J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012
[TBL] [Abstract][Full Text] [Related]
26. The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.
Groettrup M; Ruppert T; Kuehn L; Seeger M; Standera S; Koszinowski U; Kloetzel PM
J Biol Chem; 1995 Oct; 270(40):23808-15. PubMed ID: 7559557
[TBL] [Abstract][Full Text] [Related]
27. Role of proteasomes in antigen presentation.
Gaczynska M; Rock KL; Goldberg AL
Enzyme Protein; 1993; 47(4-6):354-69. PubMed ID: 7697133
[TBL] [Abstract][Full Text] [Related]
28. Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro.
Moradpour D; Grabscheid B; Kammer AR; Schmidtke G; Groettrup M; Blum HE; Cerny A
Hepatology; 2001 May; 33(5):1282-7. PubMed ID: 11343257
[TBL] [Abstract][Full Text] [Related]
29. Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide.
Stohwasser R; Giesebrecht J; Kraft R; Müller EC; Häusler KG; Kettenmann H; Hanisch UK; Kloetzel PM
Glia; 2000 Feb; 29(4):355-65. PubMed ID: 10652445
[TBL] [Abstract][Full Text] [Related]
30. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
López D; Del Val M
J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
[TBL] [Abstract][Full Text] [Related]
31. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
Sun Y; Sijts AJ; Song M; Janek K; Nussbaum AK; Kral S; Schirle M; Stevanovic S; Paschen A; Schild H; Kloetzel PM; Schadendorf D
Cancer Res; 2002 May; 62(10):2875-82. PubMed ID: 12019167
[TBL] [Abstract][Full Text] [Related]
32. [Intracellular processing of viral and tumor antigens by proteasomes].
Groettrup M; Schmidtke G
Schweiz Med Wochenschr; 1999 Nov; 129(44):1660-5. PubMed ID: 10588025
[TBL] [Abstract][Full Text] [Related]
33. LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes.
Sibille C; Gould KG; Willard-Gallo K; Thomson S; Rivett AJ; Powis S; Butcher GW; De Baetselier P
Curr Biol; 1995 Aug; 5(8):923-30. PubMed ID: 7583150
[TBL] [Abstract][Full Text] [Related]
34. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.
Kloetzel PM; Soza A; Stohwasser R
Biol Chem; 1999 Mar; 380(3):293-7. PubMed ID: 10223331
[TBL] [Abstract][Full Text] [Related]
35. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes.
Brown MG; Driscoll J; Monaco JJ
Nature; 1991 Sep; 353(6342):355-7. PubMed ID: 1922341
[TBL] [Abstract][Full Text] [Related]
36. A role for the proteasome regulator PA28alpha in antigen presentation.
Groettrup M; Soza A; Eggers M; Kuehn L; Dick TP; Schild H; Rammensee HG; Koszinowski UH; Kloetzel PM
Nature; 1996 May; 381(6578):166-8. PubMed ID: 8610016
[TBL] [Abstract][Full Text] [Related]
37. Proteolysis and class I major histocompatibility complex antigen presentation.
York IA; Goldberg AL; Mo XY; Rock KL
Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936
[TBL] [Abstract][Full Text] [Related]
38. [Antigen presentation and macrophages].
Toubert A; Charron D
Pathol Biol (Paris); 1997 Feb; 45(2):126-30. PubMed ID: 9247034
[TBL] [Abstract][Full Text] [Related]
39. Evolution of proteasome subunits delta and LMP2: complementary DNA cloning and linkage analysis with MHC in lower vertebrates.
Nonaka M; Namikawa-Yamada C; Sasaki M; Salter-Cid L; Flajnik MF
J Immunol; 1997 Jul; 159(2):734-40. PubMed ID: 9218589
[TBL] [Abstract][Full Text] [Related]
40. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes.
Boes B; Hengel H; Ruppert T; Multhaup G; Koszinowski UH; Kloetzel PM
J Exp Med; 1994 Mar; 179(3):901-9. PubMed ID: 8113682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
